Outlines preliminary arguments against the judge’s order to ban the drug.
the Department of Justice submitted its filing this week against a lawsuit that seeks to overturn the Food and Drug Administration’s (FDA) approval of the abortion drug mifepristone. The lawsuit was originally brought to court in November 2022 by pro-life groups and doctors, and District Judge Matthew Kacsmaryk ruled in favor of the plaintiffs in April 2023. The federal government appealed that ruling to the Supreme Court, and the Supreme Court put a pause on the district judge’s decision, sending the case back to a lower appeals court to be reviewed and reprocessed.
The Justice Department urged the 5th Circuit Court to officially overturn Judge Kacsmaryk’s order to strike down mifepristone’s FDA approval. “The district court’s order would thwart FDA’s scientific judgment and profoundly harm women who rely on mifepristone as an alternative to more burdensome and invasive surgical abortions,” the Justice Department wrote. Pharmaceutical companies have also strongly opposed Judge Kacsmaryk’s order, saying that the order creates a precedent to legally challenge all of the FDA’s formal approvals.
As the Lord Leads, Pray with Us…
- For Attorney General Merrick Garland to seek God’s direction as he heads the Justice Department.
- For DOJ officials as they defend the FDA’s approval of mifepristone.
- For the hearts and minds of Americans to be drawn to the Lord regarding the right to life.
Sources: Reuters, The Hill
